Integration of cytogenomic data for furthering the characterization of pediatric B-ALL: a multi-institution, multi-platform microarray study

por Baughn, LB, Biegel, JA, South, ST, Smolarek, T, Volkert, S, Carroll, A, Heerema, NA, Rabin, KR, Zweidler-McKay, PA, Loh, M, Hirsch, B
Publicado en Cancer Genet (2014)

Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements

por De Lorenzo, P, Moorman, AV, Pieters, R, Dreyer, ZE, Heerema, NA, Carroll, AJ, Hunger, SP, Harvey, R, Willman, CL, Devidas, M, Valsecchi, M-G, Harrison, CJ
Publicado en Leukemia (2013)

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell Non-Hodgkin’s Lymphoma: Results of the FAB/LM...

por Poirel, HA, Cairo, MS, Heerema, NA, Swansbury, J, Aupérin, A, Launay, E, Sanger, WG, Talley, P, Perkins, SL, Raphaël, M, McCarthy, K, Sposto, R, Gerrard, M, Bernheim, A, Patte, C
Publicado 2008

A Pilot Study of Intensified PEG-Asparaginase in High Risk Acute Lymphoblastic Leukemia: Children’s Oncology Group Study AALL08P1

por Rodriguez, V, Kairalla, J, Salzer, W, Raetz, E, Loh, ML, Carroll, A, Heerema, NA, Wood, B, Borowitz, MJ, Burke, MJ, Asselin, BL, Devidas, M, Winick, NW, Carroll, WL, Hunger, SP, Dreyer, ZE
Publicado en J Pediatr Hematol Oncol (2016)

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children’s Oncology Group Study AALL0031

por Schultz, KR, Carroll, A, Heerema, NA, Bowman, WP, Aledo, A, Slayton, WB, Sather, H, Devidas, M, Zheng, HW, Davies, SM, Gaynon, PS, Trigg, M, Rutledge, R, Jorstad, D, Winick, N, Borowitz, MJ, Hunger, SP, Carroll, WL, Camitta, B
Publicado en Leukemia (2014)

An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome

por Harrison, CJ, Moorman, AV, Schwab, C, Carroll, AJ, Raetz, EA, Devidas, M, Strehl, S, Nebral, K, Harbott, J, Teigler-Schlegel, A, Zimmerman, M, Dastuge, N, Baruchel, A, Soulier, J, Auclerc, M-F, Attarbaschi, A, Mann, G, Stark, B, Cazzaniga, G, Chilton, L, Vandenberghe, P, Forestier, E, Haltrich, I, Raimondi, SC, Parihar, M, Bourquin, J-P, Tchinda, J, Haferlach, C, Vora, A, Hunger, SP, Heerema, NA, Haas, OA
Publicado en Leukemia (2013)

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

por Woyach, J.A., Ruppert, A.S., Heerema, N.A., Zhao, W., Booth, A.M., Ding, W., Bartlett, N.L., Brander, D.M., Barr, P.M., Rogers, K.A., Parikh, S.A., Coutre, S., Hurria, A., Brown, J.R., Lozanski, G., Blachly, J.S., Ozer, H.G., Major-Elechi, B., Fruth, B., Nattam, S., Larson, R.A., Erba, H., Litzow, M., Owen, C., Kuzma, C., Abramson, J.S., Little, R.F., Smith, S.E., Stone, R.M., Mandrekar, S.J., Byrd, J.C.
Publicado en N Engl J Med (2018)

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

por Roberts, K.G., Li, Y., Payne-Turner, D., Harvey, R.C., Yang, Y.-L., Pei, D., McCastlain, K., Ding, L., Lu, C., Song, G., Ma, J., Becksfort, J., Rusch, M., Chen, S.-C., Easton, J., Cheng, J., Boggs, K., Santiago-Morales, N., Iacobucci, I., Fulton, R.S., Wen, J., Valentine, M., Cheng, C., Paugh, S.W., Devidas, M., Chen, I-M., Reshmi, S., Smith, A., Hedlund, E., Gupta, P., Nagahawatte, P., Wu, G., Chen, X., Yergeau, D., Vadodaria, B., Mulder, H., Winick, N.J., Larsen, E.C., Carroll, W.L., Heerema, N.A., Carroll, A.J., Grayson, G., Tasian, S.K., Moore, A.S., Keller, F., Frei-Jones, M., Whitlock, J.A., Raetz, E.A., White, D.L., Hughes, T.P., Auvil, J.M. Guidry, Smith, M.A., Marcucci, G., Bloomfield, C.D., Mrózek, K., Kohlschmidt, J., Stock, W., Kornblau, S.M., Konopleva, M., Paietta, E., Pui, C.-H., Jeha, S., Relling, M.V., Evans, W.E., Gerhard, D.S., Gastier-Foster, J.M., Mardis, E., Wilson, R.K., Loh, M.L., Downing, J.R., Hunger, S.P., Willman, C.L., Zhang, J., Mullighan, C.G.
Publicado 2014